nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Skin necrosis—Aminophylline—chronic obstructive pulmonary disease	0.0379	0.0622	CcSEcCtD
Terlipressin—AVPR1A—respiratory system—chronic obstructive pulmonary disease	0.0355	0.357	CbGeAlD
Terlipressin—AVPR2—respiratory system—chronic obstructive pulmonary disease	0.0294	0.296	CbGeAlD
Terlipressin—Fluid overload—Aminophylline—chronic obstructive pulmonary disease	0.0213	0.035	CcSEcCtD
Terlipressin—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.0196	0.0322	CcSEcCtD
Terlipressin—AVPR1A—lung—chronic obstructive pulmonary disease	0.0189	0.19	CbGeAlD
Terlipressin—AVPR2—lung—chronic obstructive pulmonary disease	0.0156	0.157	CbGeAlD
Terlipressin—Fluid overload—Salbutamol—chronic obstructive pulmonary disease	0.0153	0.0251	CcSEcCtD
Terlipressin—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.0152	0.025	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.0146	0.0241	CcSEcCtD
Terlipressin—AVPR1B—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0145	0.0514	CbGpPWpGaD
Terlipressin—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.0126	0.0208	CcSEcCtD
Terlipressin—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.0115	0.0188	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.0111	0.0183	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.0111	0.0183	CcSEcCtD
Terlipressin—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.0101	0.0167	CcSEcCtD
Terlipressin—AVPR1A—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0101	0.0356	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.01	0.0354	CbGpPWpGaD
Terlipressin—Octreotide—MPO—chronic obstructive pulmonary disease	0.00958	1	CrCbGaD
Terlipressin—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00924	0.0152	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—ADRB2—chronic obstructive pulmonary disease	0.00902	0.0319	CbGpPWpGaD
Terlipressin—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00867	0.0143	CcSEcCtD
Terlipressin—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.00846	0.0139	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.00821	0.029	CbGpPWpGaD
Terlipressin—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00771	0.0127	CcSEcCtD
Terlipressin—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.00771	0.0127	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00733	0.012	CcSEcCtD
Terlipressin—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00728	0.012	CcSEcCtD
Terlipressin—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00694	0.0114	CcSEcCtD
Terlipressin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00687	0.0113	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00683	0.0242	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00611	0.01	CcSEcCtD
Terlipressin—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00568	0.00934	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00564	0.0199	CbGpPWpGaD
Terlipressin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00559	0.00919	CcSEcCtD
Terlipressin—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00555	0.00912	CcSEcCtD
Terlipressin—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00555	0.00912	CcSEcCtD
Terlipressin—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00552	0.00907	CcSEcCtD
Terlipressin—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00552	0.00907	CcSEcCtD
Terlipressin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00545	0.00896	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00535	0.0189	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00502	0.0178	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00485	0.00798	CcSEcCtD
Terlipressin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00484	0.00796	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00474	0.0168	CbGpPWpGaD
Terlipressin—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00471	0.00774	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.0047	0.0166	CbGpPWpGaD
Terlipressin—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00469	0.00771	CcSEcCtD
Terlipressin—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00469	0.00771	CcSEcCtD
Terlipressin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00464	0.00763	CcSEcCtD
Terlipressin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00463	0.00761	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00461	0.00758	CcSEcCtD
Terlipressin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00461	0.00757	CcSEcCtD
Terlipressin—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00459	0.00755	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00458	0.0162	CbGpPWpGaD
Terlipressin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0045	0.0074	CcSEcCtD
Terlipressin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00443	0.00729	CcSEcCtD
Terlipressin—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00443	0.00728	CcSEcCtD
Terlipressin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.0044	0.00723	CcSEcCtD
Terlipressin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.0044	0.00723	CcSEcCtD
Terlipressin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00436	0.00717	CcSEcCtD
Terlipressin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00434	0.00714	CcSEcCtD
Terlipressin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00433	0.00712	CcSEcCtD
Terlipressin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00432	0.00711	CcSEcCtD
Terlipressin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0042	0.00691	CcSEcCtD
Terlipressin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00415	0.00683	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00415	0.0147	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00388	0.0137	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00384	0.00632	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00383	0.0136	CbGpPWpGaD
Terlipressin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.0038	0.00624	CcSEcCtD
Terlipressin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.0038	0.00624	CcSEcCtD
Terlipressin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00378	0.00622	CcSEcCtD
Terlipressin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00375	0.00616	CcSEcCtD
Terlipressin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00375	0.00616	CcSEcCtD
Terlipressin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00373	0.00613	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00372	0.00612	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00372	0.00612	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00371	0.0131	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00368	0.013	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00364	0.00599	CcSEcCtD
Terlipressin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.0059	CcSEcCtD
Terlipressin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00354	0.00581	CcSEcCtD
Terlipressin—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00353	0.0058	CcSEcCtD
Terlipressin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00352	0.00579	CcSEcCtD
Terlipressin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00352	0.00579	CcSEcCtD
Terlipressin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00352	0.00578	CcSEcCtD
Terlipressin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0035	0.00576	CcSEcCtD
Terlipressin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0035	0.00576	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00349	0.0123	CbGpPWpGaD
Terlipressin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00349	0.00573	CcSEcCtD
Terlipressin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00349	0.00573	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00347	0.0123	CbGpPWpGaD
Terlipressin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00345	0.00567	CcSEcCtD
Terlipressin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00342	0.00562	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00339	0.012	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00336	0.0119	CbGpPWpGaD
Terlipressin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00547	CcSEcCtD
Terlipressin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00331	0.00544	CcSEcCtD
Terlipressin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00329	0.00541	CcSEcCtD
Terlipressin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00323	0.00531	CcSEcCtD
Terlipressin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00526	CcSEcCtD
Terlipressin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00526	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00318	0.0112	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00315	0.0112	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.0031	0.0051	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.0031	0.0051	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00304	0.00499	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00304	0.0107	CbGpPWpGaD
Terlipressin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00497	CcSEcCtD
Terlipressin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00301	0.00494	CcSEcCtD
Terlipressin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.003	0.00493	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00299	0.00491	CcSEcCtD
Terlipressin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00296	0.00486	CcSEcCtD
Terlipressin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00295	0.00484	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00481	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00288	0.0102	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00286	0.0101	CbGpPWpGaD
Terlipressin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00467	CcSEcCtD
Terlipressin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00467	CcSEcCtD
Terlipressin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00465	CcSEcCtD
Terlipressin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0028	0.00461	CcSEcCtD
Terlipressin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00279	0.00458	CcSEcCtD
Terlipressin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00279	0.00458	CcSEcCtD
Terlipressin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00457	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00269	0.00951	CbGpPWpGaD
Terlipressin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00441	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00266	0.00939	CbGpPWpGaD
Terlipressin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00264	0.00434	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00264	0.00933	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00262	0.00928	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00257	0.00909	CbGpPWpGaD
Terlipressin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.00404	CcSEcCtD
Terlipressin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00246	0.00404	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00245	0.00866	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00242	0.00856	CbGpPWpGaD
Terlipressin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00241	0.00396	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00241	0.00851	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0024	0.0085	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00235	0.00832	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00233	0.00823	CbGpPWpGaD
Terlipressin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.00381	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00231	0.00817	CbGpPWpGaD
Terlipressin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00375	CcSEcCtD
Terlipressin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00375	CcSEcCtD
Terlipressin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00225	0.0037	CcSEcCtD
Terlipressin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00225	0.0037	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00225	0.00795	CbGpPWpGaD
Terlipressin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00368	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00222	0.00786	CbGpPWpGaD
Terlipressin—Headache—Montelukast—chronic obstructive pulmonary disease	0.0022	0.00362	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00219	0.00775	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00359	CcSEcCtD
Terlipressin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00217	0.00357	CcSEcCtD
Terlipressin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00354	CcSEcCtD
Terlipressin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00351	CcSEcCtD
Terlipressin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00351	CcSEcCtD
Terlipressin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00212	0.00349	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.0021	0.00744	CbGpPWpGaD
Terlipressin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00343	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00207	0.00732	CbGpPWpGaD
Terlipressin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00338	CcSEcCtD
Terlipressin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00203	0.00333	CcSEcCtD
Terlipressin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00331	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00199	0.00705	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00198	0.00701	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00198	0.007	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00197	0.00698	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00197	0.00696	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00196	0.00692	CbGpPWpGaD
Terlipressin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00312	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00182	0.00643	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00181	0.00639	CbGpPWpGaD
Terlipressin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00297	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00179	0.00634	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00178	0.0063	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00177	0.00626	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00173	0.00613	CbGpPWpGaD
Terlipressin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00173	0.00285	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00171	0.00606	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.0017	0.006	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00168	0.00596	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00156	0.00551	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00155	0.00547	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00154	0.00545	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00153	0.00541	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00152	0.00537	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00151	0.00533	CbGpPWpGaD
Terlipressin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00246	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00241	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00144	0.00508	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00142	0.00504	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00139	0.00491	CbGpPWpGaD
Terlipressin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00228	CcSEcCtD
Terlipressin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00227	CcSEcCtD
Terlipressin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00226	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00137	0.00485	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00137	0.00484	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00136	0.0048	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00136	0.0048	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00135	0.00476	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00131	0.00464	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00124	0.00439	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00124	0.00438	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00123	0.00436	CbGpPWpGaD
Terlipressin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.002	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.0012	0.00425	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00119	0.00422	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00119	0.0042	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00118	0.00417	CbGpPWpGaD
Terlipressin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.0019	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00112	0.00398	CbGpPWpGaD
Terlipressin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00184	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00111	0.00391	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00111	0.00391	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00106	0.00374	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00106	0.00374	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00105	0.00373	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.001	0.00355	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000967	0.00342	CbGpPWpGaD
Terlipressin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000967	0.00159	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000963	0.00341	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000956	0.00338	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00095	0.00336	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00091	0.00322	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000904	0.0032	CbGpPWpGaD
Terlipressin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000899	0.00148	CcSEcCtD
Terlipressin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000885	0.00146	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000879	0.00311	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000858	0.00303	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000852	0.00301	CbGpPWpGaD
Terlipressin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000839	0.00138	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000779	0.00276	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000774	0.00274	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000773	0.00274	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000767	0.00271	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000761	0.00269	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000734	0.00259	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000733	0.00259	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00073	0.00258	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000728	0.00258	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000728	0.00257	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000719	0.00254	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000696	0.00246	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000691	0.00244	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000671	0.00237	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000666	0.00236	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000664	0.00235	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000664	0.00235	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000609	0.00215	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000605	0.00214	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000598	0.00211	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000593	0.0021	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000543	0.00192	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000539	0.00191	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000536	0.0019	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000533	0.00188	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000519	0.00184	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000499	0.00176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000495	0.00175	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000483	0.00171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00046	0.00163	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000457	0.00162	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000414	0.00147	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000411	0.00146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000411	0.00145	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000408	0.00144	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000397	0.0014	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000379	0.00134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000376	0.00133	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000374	0.00132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000374	0.00132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000371	0.00131	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000361	0.00128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00036	0.00127	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000357	0.00126	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000334	0.00118	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000332	0.00117	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000321	0.00113	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000305	0.00108	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.00029	0.00103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000275	0.000973	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000273	0.000966	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000262	0.000928	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000261	0.000922	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.00026	0.000921	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000251	0.000886	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000249	0.00088	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000239	0.000846	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000234	0.000829	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000222	0.000786	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000221	0.000781	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000211	0.000748	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.00021	0.000742	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000201	0.000711	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.0002	0.000706	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000197	0.000696	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000181	0.000639	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.00018	0.000637	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000179	0.000634	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000166	0.000586	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000164	0.000582	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000162	0.000575	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000161	0.000571	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000136	0.000482	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000135	0.000479	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000125	0.000442	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000124	0.000438	CbGpPWpGaD
